Neurona Therapeutics is a company that strives to develop clinical-stage biotherapeutic treatments for neurological disorders with a focus on advancing regenerative cell therapy candidates. The company researches allogeneic therapies that come from stem cells harvested from donors. Neurona's proprietary therapy NRTX-1001 aims to reverse the effects of Alzheimer’s disease and other nervous system disorders. Neurona Therapeutics was founded by Arnold Kriegstein and Cory R. Nicholasin in 2008 and is headquartered in San Francisco, CA.

Register for Details

For more details on financing and valuation for Neurona Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Neurona Therapeutics

Forge green plus iconForge green minus icon

What is Neurona Therapeutics's IPO price?

The IPO price for Neurona Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Neurona Therapeutics?

Neurona Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Neurona Therapeutics shares pre-IPO?

If you own Neurona Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Neurona Therapeutics a publicly traded company?

Neurona Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Neurona Therapeutics's funding to date?

Neurona Therapeutics has raised $240.58MM to date.
Forge green plus iconForge green minus icon

When was Neurona Therapeutics founded?

Neurona Therapeutics was founded in 2008.

Who are Neurona Therapeutics's major investors?

Viking Global Investors
Euclidean Capital
Ironfire Ventures
Cormorant Asset Management
Spur Capital Partners
National Institutes of Health
The Column Group
SymBiosis Capital Management
Ysios Capital
UC Investments
LYFE Capital
Schroders Capital
UCB Ventures
California Institute for Regenerative Medicine
SC Launch
Topspin Consumer Partners
Sphera Funds Management
Harvard University Endowment
Berkeley Frontier Fund
Willett Advisors

Neurona Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
2/8/2024 Series E $120MM raised $XXX.XX $XXX.XX
3/19/2021 Series D $72.01MM raised $XXX.XX $XXX.XX
11/18/2019 Series C $15.03MM raised $XXX.XX $XXX.XX
2/8/2018 Series B $10.04MM raised $XXX.XX $XXX.XX
12/1/2015 Series A $23.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 21, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.